SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

LUNGHI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.181
AS - Asia 3.643
EU - Europa 1.957
SA - Sud America 578
AF - Africa 89
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.041
SG - Singapore 1.352
CN - Cina 893
VN - Vietnam 452
BR - Brasile 433
DE - Germania 370
UA - Ucraina 329
IT - Italia 312
HK - Hong Kong 311
GB - Regno Unito 212
TR - Turchia 186
FR - Francia 126
FI - Finlandia 125
JP - Giappone 113
PL - Polonia 100
SE - Svezia 90
RU - Federazione Russa 78
IN - India 76
CA - Canada 69
ID - Indonesia 56
MX - Messico 56
AR - Argentina 51
NL - Olanda 51
BD - Bangladesh 44
BE - Belgio 35
ZA - Sudafrica 33
IQ - Iraq 31
EC - Ecuador 24
PK - Pakistan 22
ES - Italia 21
CZ - Repubblica Ceca 18
CO - Colombia 17
AT - Austria 16
MY - Malesia 15
VE - Venezuela 15
PH - Filippine 14
CL - Cile 12
LT - Lituania 12
CH - Svizzera 10
JO - Giordania 10
MA - Marocco 10
PY - Paraguay 10
SA - Arabia Saudita 9
GR - Grecia 8
IR - Iran 8
RO - Romania 8
NP - Nepal 7
TN - Tunisia 7
UZ - Uzbekistan 7
KE - Kenya 6
PE - Perù 6
UY - Uruguay 6
DZ - Algeria 5
ET - Etiopia 5
PT - Portogallo 5
AL - Albania 4
AU - Australia 4
CI - Costa d'Avorio 4
IE - Irlanda 4
IL - Israele 4
JM - Giamaica 4
LB - Libano 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
BG - Bulgaria 3
BO - Bolivia 3
EG - Egitto 3
KW - Kuwait 3
NO - Norvegia 3
OM - Oman 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EU - Europa 2
HU - Ungheria 2
KR - Corea 2
PR - Porto Rico 2
SI - Slovenia 2
TH - Thailandia 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
Totale 13.440
Salva come PNG Salva come JPEG
Città #
Singapore 840
Ashburn 791
Woodbridge 595
Fairfield 594
Houston 392
San Jose 379
Chandler 369
Jacksonville 345
Santa Clara 335
Hong Kong 304
Beijing 285
Seattle 263
Ann Arbor 239
New York 223
Dallas 212
Wilmington 212
Cambridge 194
Ho Chi Minh City 166
Tokyo 108
Ferrara 102
Izmir 102
Munich 101
Hanoi 99
Nanjing 99
Warsaw 96
Boardman 93
Los Angeles 88
Princeton 84
The Dalles 77
Lauterbourg 73
Council Bluffs 64
San Diego 60
Milan 48
São Paulo 46
Orem 45
Shanghai 40
Helsinki 39
Jakarta 39
Dearborn 37
Shenyang 36
Mexico City 35
Brussels 34
London 33
Chicago 32
Bremen 31
Buffalo 31
Hefei 30
Tianjin 26
Hebei 24
Frankfurt am Main 23
Chennai 22
Turku 22
Johannesburg 21
Brooklyn 20
Jiaxing 20
Phoenix 20
Nanchang 19
Nuremberg 18
Redwood City 18
Toronto 17
Changsha 16
Da Nang 16
Haiphong 16
Montreal 16
Amsterdam 15
Stockholm 15
Denver 14
San Francisco 14
Brno 13
Kunming 13
Mountain View 13
Auburn Hills 12
Des Moines 12
Düsseldorf 12
Manchester 12
Mcallen 12
Norwalk 12
Rome 12
Atlanta 11
Baghdad 11
Curitiba 11
Dong Ket 11
Falkenstein 11
Moscow 11
Vienna 11
Belo Horizonte 10
Hangzhou 10
Poplar 10
Ottawa 9
Redmond 9
Amman 8
Ankara 8
Biên Hòa 8
Charlotte 8
Jinan 8
Lahore 8
Montréal 8
Mumbai 8
San Mateo 8
Thái Bình 8
Totale 9.260
Salva come PNG Salva come JPEG
Nome #
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 346
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 293
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 283
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 261
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 249
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 246
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 244
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 244
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 241
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 241
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 237
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype 236
A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the italian population 217
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 216
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 212
A new factor V gene polymorphism (His 1254 Arg) present in subjects of African origin mimics the R2 polymorphism (His 1299 Arg) 206
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 203
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 203
A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject 198
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 198
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 197
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 195
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 191
Performance prediction models based on anthropometric, genetic and psychological traits of Croatian sprinters 188
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 186
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 185
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 185
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 185
An underestimated combination of opposites resulting in enhanced thrombotic tendency 182
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 182
The factor VIII D I24I E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels 176
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 176
Factor V gene mutations (R2 gene) are associated with coronary artery disease inelderly people 174
Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism 172
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 170
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 170
Does factor V Asp79His (409 G/C) polymorphism influence factor V and APC resistance levels? 162
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 162
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 158
Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia 158
Modulation of factor V levels in plasma by polymorphisms in the C2 domain 153
Hemostasis gene expression of the internal jugular and saphenous veins 150
Risks factors for highly unstable response to oral anticoagulation: a case-control study 149
Resistance to activated protein C, associated with oral contraceptives use; effect of formulations, duration of assumption, and doses of oestro- progestins 148
Factor V markers for the detection of genetic components of APC resi stance in venous thrombosis. 147
Venous thromboembolism in young women - Role of thrombophilic mutations and oral contraceptive use 146
Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin K-dependent coagulation factors 145
Factor V Levels in a Cohort of Patients Eligible for Oral Anticoagulant Therapy. 140
Contribution of asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms to full-length FVIII concentrate pharmacokinetics 138
The Asialoglycoprotein Receptor Minor Subunit Gene Contributes to Pharmacokinetics of Factor VIII Concentrates in Hemophilia A 138
Phenotype and genotype expression in pseudohomozygous factor V-LEIDEN - The need for phenotype analysis 136
CMR+ Factor V deficiency Arg2080Cys: A model to investigate altered C2 domain-membrane interaction. 136
Resistance to activated protein C in healthy women taking oral contraceptives 135
Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299 Arg substitutions in factor V 134
Functional genetics 134
Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis 133
Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation. 131
Combination of CLEC4M rs868875 G-Carriership and ABO O Genotypes May Predict Faster Decay of FVIII Infused in Hemophilia A Patients 131
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes 129
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 127
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation 125
Increased Susceptibility to Proteases in Type 2A von Willebrand Disease Associated with two Novel Mutations (Val 867 Glu, Pro 864 His). 121
Molecular bases of pseudo-homozygous APC resistance: The compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma 119
Polimorfismi funzionali e terapia anticoagulante 115
In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2A 110
Severe bleeding and absent ADP-induced platelet aggregation associated with inherited combined CalDAG-GEFI and P2Y12 deficiencies 106
Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women 105
Functional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentrates 102
The asymptomatic carriership of thrombophilic defects is associated with frequent genotypes of the fibrinogen gene cluster. 101
The asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms influence several parameters of full-length FVIII concentrate pharmacokinetics 99
The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms 99
Whole-Exome Sequencing in a Family with an Unexplained Tendency for Venous Thromboembolism: Multicomponent Prediction of Low-Frequency Variant Deleteriousness and of Individual Protein Interaction 97
null 95
Expression and characterization of a factor V mutation (E1608K) detected in familial thrombophilia. 94
Evaluation of FV mRNA to define the residual FV expression levels in severe FV deficiency 93
Lesioni molecolari ricorrenti sono responsabili di difetti funzionali del fattore VII. 89
Studio di mutazioni in geni dell’emostasi. 89
null 88
Detection of New Polymorphic Markers in the Factor V Gene. 87
Studio di Mutazioni in Geni dell'Emostasi. 86
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 70
Modulation of factor VIII pharmacokinetics by genetic components in factor VIII receptors 65
null 63
Association of membranous nephropathy with familial resistance to activated protein C 62
Influence of low-density lipoprotein (LDL) receptor-related protein and ABO blood group genotypes on factor XI levels. 61
Factor V Kuwait alias factor V R3: A rare polymorphism of uncertain functional significance 53
Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis 33
Genetic components in factor VIII receptors for individual and genotype-modeled hemophilia A treatment 30
Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited 19
Genetic determinants of activated factor VII-antithrombin plasma levels and mortality in patients with coronary artery disease 13
Totale 13.597
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.665
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021328 0 0 0 0 0 0 0 0 0 138 134 56
2021/2022903 96 87 47 71 50 18 54 47 21 59 83 270
2022/2023902 93 78 24 109 130 130 67 76 100 15 46 34
2023/2024563 34 39 18 20 36 183 9 26 17 7 13 161
2024/20251.870 44 31 172 66 243 169 46 77 316 219 275 212
2025/20265.071 524 222 523 704 758 356 620 311 547 506 0 0
Totale 13.597